Skip to main content

Timothy Scannell

Equibles does not estimate personal net worth.

Get an email with a short summary when NovoCure Ltd publishes a filing, an earnings call transcript or a press release.

Get NVCR alerts

About Timothy Scannell

Timothy Scannell is recorded as Board Member at NovoCure Ltd (NVCR) since June 5, 2024 and COO at NovoCure Ltd (NVCR). The newest filing on record that lists Timothy Scannell as COO at NovoCure Ltd (NVCR) is dated April 20, 2026. NovoCure Ltd reported in an 8-K filed September 9, 2026 that Timothy Scannell retired as director, effective September 2, 2026. NovoCure Ltd reported in an 8-K filed June 5, 2026 that Timothy Scannell was appointed director, effective June 3, 2026. NovoCure Ltd reported in an 8-K filed June 6, 2025 that Timothy Scannell was appointed director, effective June 4, 2025. Equibles holds 5 filed executive changes naming Timothy Scannell; each is listed under recent activity with its source filing. NovoCure Ltd is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at NovoCure Ltd includes Asaf Danziger (CEO and Board Member), David Hung (CEO and Board Member), Frank Leonard (CEO and Board Member) and 7 others.

“Timothy Scannell, a current director of NovoCure Limited (the "Company"), has retired from the Board and his seat was formally vacated pursuant to the Company's Articles of Association effective September 2, 2026.”
NovoCure Ltd Form 8-K, filed September 9, 2026 · Read the filing
“The Company’s shareholders elected Asaf Danziger, William Doyle, Jeryl Hilleman, David Hung, Frank Leonard, Kinyip Gabriel Leung, Martin Madden, Allyson Ocean, Timothy Scannell, Kristin Stafford and William Vernon as directors, effective immediately, with a term expiring at the annual meeting of shareholders in 2027.”
NovoCure Ltd Form 8-K, filed June 5, 2026 · Read the filing

Affiliation history

Company network

Current role

Medical Devices · Healthcare

COO, Board Member

2021-01-01–present

Leadership on record at NovoCure Ltd

Recent activity